	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	06/04/2020
	www.isa.gov.il			www.tase.co.il				Reference:	2020-02-032371	Time of broadcast: 23:56 23:55:57

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Form 10-Q

ORAMEDPHARMINC_10Q_20200406_isa.pdf

Link to filing on foreign stock exchange (optional): _________


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 18/02/2020
Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: GABAY AVRAHAM Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 91390 Telephone: 052-5779725 Facsimile: 02-5660004 E-mail: Avi@oramed.com 2
USA